Deciphering biology,
discovering new anti-infectives

through deep phenotypic insights and machine learning


Discovering new classes of anti-infectives to overcome drug resistant infections.

Our machine learning (ML)-based imaging platform for anti-infective drug discovery enables rapid and highly efficient identification of compounds with new and unexploited mechanisms of action at the very outset of the discovery process.

Our combined expertise, cutting edge technologies and novel workflows enable a rapid and early understanding of a compound’s mechanism of action, the potential addressable target product profile, and clinical utility based on deep analysis of cell behavior.

Explore Platform

Delivering new classes of anti-infectives.

ArrePath is applying its technology platform to develop a pipeline of new classes of antibiotics,
targeting unexploited and under-exploited mechanisms of action, to address unmet clinical need and overcome drug resistance.

Discover Strategy

Recent News and Updates

  • Cytodata 2022


    ArrePath will be attending the seventh annual CytoData meeting, hosted by the Allen Institute for Cell Science, which will take place October 17-20, 2022 in Seattle, Washington.

    Calendar 08-25-2022
  • World anti-microbial congress logo

    World Anti-Microbial Resistance Congress 2022

    ArrePath is attending the World Anti-Microbial Resistance Congress taking place on September 7-8, 2022, in National Harbor, MD.

    Calendar 08-08-2022
  • NeurIPS 2022

    2022 Conference on Neural Information Processing Systems

    Join ArrePath at 2022 NeurIPS, a premier conference on Machine Learning and AI. This event is taking place at the New Orleans Convention Center on Monday, November 28th – Friday, December 9th.

    Calendar 08-01-2022